A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
1 other identifier
observational
338
1 country
1
Brief Summary
The introduction of unfractionated heparin (UFH), which prevents clotting of the extracorporal circuit, was one of the key advances that led to the rapid development and expansion of hemodialysis services. However, anticoagulation during hemodialysis of the patient at high risk for bleeding remains a frequently encountered problem in both inpatient and outpatient dialysis practice. Streamline bloodlines are designed to eliminate blood-air contact. This is thought to help reduce heparin use and decrease clotting rates. The goal of this study was to prospectively examine impact of the Streamline airless blood tubing set, in an inpatient setting, on dialysis circuit clotting rates, anticoagulation use, and dialysis efficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 10, 2014
CompletedFirst Posted
Study publicly available on registry
March 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedResults Posted
Study results publicly available
July 15, 2019
CompletedJuly 15, 2019
May 1, 2019
1.6 years
March 10, 2014
September 13, 2017
May 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clotting of Extracorporeal Dialysis Circuit
Each dialysis session was prospectively observed for Clotting of Extracorporeal Dialysis Circuit. Events were defined as interruption of hemodialysis session, loss of the hemodialysis circuit, or inability to return blood to the patient upon rinse back.
During the dialysis session, approximately 211 minutes
Study Arms (2)
General Care Cohort
The group included adult hospitalized patients requiring hemodialysis at the inpatient dialysis unit. This was an observational study, with no interventions.
Critical Care Cohort
The group included adult hospitalized patients requiring hemodialysis at the intensive care unit. This was an observational study, with no interventions.
Eligibility Criteria
The group included adult hospitalized patients requiring hemodialysis at the inpatient dialysis unit or the ICU during the recruitment period.
You may qualify if:
- All adult non-pregnant patients requiring inpatient hemodialysis at our center during the recruitment period until the target sample of dialysis sessions (n=1200) was reached.
You may not qualify if:
- Pregnant females
- Children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Marie Hoganlead
- NxStage Medicalcollaborator
Study Sites (1)
Mayo Clinic Hospital, Saint Marys Campus
Rochester, Minnesota, 55902, United States
Related Publications (1)
Safadi S, Albright RC Jr, Dillon JJ, Williams AW, Alahdab F, Brown JK, Severson AL, Kremers WK, Ryan MA, Hogan MC. Prospective Study of Routine Heparin Avoidance Hemodialysis in a Tertiary Acute Care Inpatient Practice. Kidney Int Rep. 2017 Mar 16;2(4):695-704. doi: 10.1016/j.ekir.2017.03.003. eCollection 2017 Jul.
PMID: 29142987RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Marie Hogan
- Organization
- Mayo Clinic
Study Officials
- PRINCIPAL INVESTIGATOR
Marie C. Hogan, M.D., Ph.D.
Mayo Clinic
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
March 10, 2014
First Posted
March 13, 2014
Study Start
January 1, 2014
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
July 15, 2019
Results First Posted
July 15, 2019
Record last verified: 2019-05